A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Clinical trial NCT04928677 · RECRUITING

Trial details

NCT number: NCT04928677
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Extra-cranial Solid Tumor Recurrent or Refractory Glypican 3 (GPC3)

Start date: 2021-06-09
Primary completion: 2027-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.